Lonhala Magnair Side Effects
Generic name: glycopyrrolate
Medically reviewed by Drugs.com. Last updated on Feb 6, 2024.
Note: This document provides detailed information about Lonhala Magnair.
For healthcare professionals
Applies to glycopyrrolate: compounding powder, inhalation capsule, inhalation solution, injectable solution, intravenous solution, oral solution, oral tablet, oral tablet disintegrating Side Effects associated with glycopyrrolate. Some dosage forms listed on this page may not apply specifically to the brand name Lonhala Magnair.
For healthcare professionals
Applies to glycopyrrolate: compounding powder, inhalation capsule, inhalation solution, injectable solution, intravenous solution, oral solution, oral tablet, oral tablet disintegrating.
Gastrointestinal
- Very common (10% or more): Dry mouth (40%), vomiting (40%), constipation (35%)
- Frequency not reported: Abdominal distension, abdominal pain, stomach discomfort, chapped lips, flatulence, retching, dry tongue[Ref]
Cardiovascular
- Very common (10% or more): Flushing (30%)
- Frequency not reported: Heart rate increase, pallor[Ref]
Nervous system
- Very common (10% or more): Headache (15%)
- Frequency not reported: Convulsion, dysgeusia, nystagmus
- Postmarketing reports: Loss of taste[Ref]
Genitourinary
- Very common (10% or more): Urinary retention (15%)
- Postmarketing reports: Suppression of lactation[Ref]
Immunologic
- Very common (10% or more): Sinusitis (15%), upper respiratory tract infection (15%)
- Frequency not reported: Pneumonia, tracheostomy infection, urinary tract infection[Ref]
Respiratory
- Very common (10% or more): Nasal congestion (30%)
- Frequency not reported: Increased viscosity of bronchial secretion, nasal dryness[Ref]
Psychiatric
- Frequency not reported: Irritability, agitation, restlessness, abnormal behavior, aggression, crying, impulse control disorder, moaning, mood altered[Ref]
Dermatologic
Metabolic
- Frequency not reported: Dehydration[Ref]
Other
- Frequency not reported: Pain[Ref]
References
1. (2010) "Product Information. Cuvposa (glycopyrrolate)." Shionogi USA Inc
Frequently asked questions
More about Lonhala Magnair (glycopyrrolate)
- Check interactions
- Compare alternatives
- Reviews (1)
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anticholinergic bronchodilators
- Breastfeeding
Patient resources
- Lonhala Magnair Refill Kit inhalation drug information
- Lonhala Magnair Starter Kit inhalation
- Lonhala Magnair (Advanced Reading)
Other brands
Robinul, Seebri Neohaler, Cuvposa, Dartisla ODT, ... +2 more
Professional resources
Other brands
Robinul, Seebri Neohaler, Cuvposa, Dartisla ODT, Glyrx-PF
Related treatment guides
Further information
Lonhala Magnair side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.